Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance) (c. 536)

ANNEX IV U.K. CONTENT OF THE SUMMARY OF THE RESULTS OF THE CLINICAL TRIAL

B. SUBJECT DISPOSITION: U.K.

1.

Recruitment (including information on the number of subjects screened, recruited and withdrawn; inclusion and exclusion criteria; randomisation and blinding details; investigational medicinal products used);

2.

Pre-assignment Period;

3.

Post Assignment Periods.